This inventor holds 4 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Conagen Inc.. Active years: 2020-2023.
Company Filing History:
Years Active: 2020-2023
Title: Yilin Wu: Innovator in Biosynthetic Production
Introduction
Yilin Wu is a prominent inventor based in Wuxi, China. She has made significant contributions to the field of biosynthetic production, particularly in the development of steviol glycosides. With a total of 4 patents to her name, Yilin is recognized for her innovative approaches and methodologies.
Latest Patents
Yilin Wu's latest patents include groundbreaking work on the biosynthetic production of steviol glycosides. One of her notable inventions is the production of steviol glycoside rebaudiosides D4, WB1, and WB2, as well as the production of rebaudioside M from Reb D4. Another significant patent focuses on the biosynthetic production of rebaudioside D4 from rebaudioside E, which involves the use of mutant CP1 and HV1 enzymes, along with host cells and methods to enhance production efficiency.
Career Highlights
Yilin Wu is currently associated with Conagen Inc., a company known for its innovative solutions in biotechnology. Her work has positioned her as a key player in the field, contributing to advancements in sustainable production methods.
Collaborations
Yilin has collaborated with notable colleagues, including Guohong Mao and Jacob Edward Vick. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Yilin Wu's contributions to the field of biosynthetic production exemplify her innovative spirit and dedication to advancing technology. Her work continues to influence the industry and pave the way for future developments in sustainable practices.